
Investing.com – France stocks were higher after the close on Monday, as gains in the Healthcare, Oil&Gas and Consumer Services sectors led shares higher.
At the close in Paris, the CAC 40 gained 1.83%, while the SBF 120 index gained 1.88%.
The best performers of the session on the CAC 40 were Renault SA (EPA:RENA), which rose 3.90% or 1.20 points to trade at 31.95 at the close. Meanwhile, Publicis Groupe SA (EPA:PUBP) added 3.55% or 1.90 points to end at 55.48 and Kering SA (EPA:PRTP) was up 3.33% or 14.90 points to 462.90 in late trade.
The worst performers of the session were Air Liquide SA (EPA:AIRP), which rose 0.15% or 0.18 points to trade at 118.82 at the close. Danone SA (EPA:DANO) added 0.57% or 0.28 points to end at 48.25 and L’Oreal SA (EPA:OREP) was up 0.66% or 2.15 points to 328.50.
The top performers on the SBF 120 were Orpea SA (EPA:ORP) which rose 10.50% to 11.84, Vallourec (EPA:VLLP) which was up 9.70% to settle at 10.66 and Valneva (EPA:VLS) which gained 6.46% to close at 6.69.
The worst performers were Virbac SA (EPA:VIRB) which was down 2.91% to 284.00 in late trade, Gaztransport et Technigaz SA (EPA:GTT) which lost 1.06% to settle at 112.40 and BIC (EPA:BICP) which was down 0.94% to 68.45 at the close.
Rising stocks outnumbered declining ones on the Paris Stock Exchange by 394 to 168 and 66 ended unchanged.
The CAC 40 VIX, which measures the implied volatility of CAC 40 options, was unchanged 0.00% to 18.96 a new 52-week high.
Gold Futures for December delivery was up 0.88% or 14.45 to $1,663.35 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in December rose 0.95% or 0.80 to hit $85.45 a barrel, while the December Brent oil contract rose 0.86% or 0.79 to trade at $92.42 a barrel.
EUR/USD was up 1.23% to 0.98, while EUR/GBP fell 0.69% to 0.86.
The US Dollar Index Futures was down 1.11% at 111.94.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.